New Clinical Trial Manager joins Maculaser
We are pleased to announce that Aki Vartiainen joins the Maculaser team as Clinical Trial Manager.Aki brings strong expertise to our […]
New Clinical Trial Manager joins Maculaser Read more ›
Maculaser secures its first Japanese patent
Maculaser has been granted a Japanese patent for its method and device for determining changes in retinal and/or brain temperature.
Maculaser secures its first Japanese patent Read more ›
New Head of Regulatory Affairs and Quality Assurance joins the team
We are excited to announce that Kirsty Happonen joins the Maculaser team as Head of Regulatory Affairs and Quality Assurance. Kirsty
New Head of Regulatory Affairs and Quality Assurance joins the team Read more ›
General Application
We are seeking talented professionals to advance our mission of preventing blindness
General Application Read more ›
Maculaser awarded Deep Tech Accelerator grant funding
Maculaser has been awarded a 400kEUR Deep Tech Accelerator grant from Business Finland. This brings our total private and public funding
Maculaser awarded Deep Tech Accelerator grant funding Read more ›
Maculaser receives Instrumentarium Science Foundation grant
Maculaser, a company developing treatments for retinal disorders that affect millions of people worldwide and that currently have no effective
Maculaser receives Instrumentarium Science Foundation grant Read more ›